ROSSARI.NS

Rossari Biotech Limited
NSEINREQUITY Basic Materials DELAYED
Last price
501.35
▼ 10.35 (2.02%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
512.35
Prev close
511.70
Day high
515.45
Day low
499.25
Volume
83.28K
Market cap
$27.79B
P/E (TTM)
18.45
52W range
375.00 – 690.30

Day trading desk

Current session · delayed
Gap from prior close
+0.13%
Prior close 511.70
VWAP
503.22
-0.37% from price
Relative volume
0.78×
Normal
Session range
2.74%
499.25 – 512.95
Position in range
15%
Near session low
ATR (14D)
14.57
2.91% of price
Prior day high
528.60
PDH
Prior day low
496.55
PDL
Bid / ask spread
Quote not published
Session volume
80.97K
Avg 103.84K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-0.25% +1.1%
1M
+1.99% -1.7%
3M
-7.72% -10.8%
6M
-1.87% -12.9%
YTD
-13.81% -26.1%
1Y
-21.60% -41.6%
3Y
-40.52% -114.7%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on ROSSARI.NS open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
37.74M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 28, 25
Chari (Jyotishna Sunil)
Promoter
GIFT 1.50M $10.57M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

1 reporting
NameRelationShares heldLatest
Chari (Jyotishna Sunil)
Promoter 2.50M Gift

Fundamentals

TTM · reported
Market cap$27.79B
Enterprise value$31.00B
Revenue (TTM)$25.50B
Gross profit$7.53B
EBITDA$2.67B
Net income$1.51B
EPS (TTM)$27.19
Free cash flow
Total cash$1.15B
Total debt$4.36B
Book value / share$240.75
Shares outstanding55.39M
Float17.64M
Short % of float
Dividend yield0.10%
Beta (5Y)0.55

Valuation & profitability ratios

Account required
Trailing P/E18.45
Forward P/E14.93
PEG ratio
Price / sales
Price / book2.08
EV / revenue1.22
EV / EBITDA11.59
Gross margin29.53%
Operating margin7.89%
Profit margin5.91%
Return on equity
Return on assets
Debt / equity32.70
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 5 quarters
Blank means not reported, not zero
Line item2026202520242023YoY
Total revenue $23.90B$20.71B$18.25B$16.51B +15.4%
Operating revenue $23.90B$20.71B$18.25B$16.51B +15.4%
Cost of revenue $16.84B$14.50B$13.04B$11.78B +16.2%
Gross profit $7.06B$6.22B$5.21B$4.73B +13.5%
Selling, general & admin $1.38B$1.23B$813.29M$828.38M +12.7%
Total operating expense $5.16B$4.34B$3.38B$3.21B +18.7%
Operating income $1.90B$1.87B$1.83B$1.52B +1.3%
Net interest income -$271.92M-$169.54M-$171.33M-$197.94M -60.4%
Pre-tax income $2.03B$1.85B$1.78B$1.44B +9.4%
Tax provision $533.02M$488.07M$469.26M$369.62M +9.2%
Net income $1.49B$1.36B$1.31B$1.07B +9.4%
Net income to common $1.49B$1.36B$1.31B$1.07B +9.4%
Basic EPS 26.9524.6623.6719.46 +9.3%
Diluted EPS 26.9324.6323.6219.38 +9.3%
EBIT $2.31B$2.03B$1.97B$1.67B +13.8%
EBITDA $3.10B$2.70B$2.57B$2.29B +14.9%
Basic shares 55.37M55.31M55.21M55.11M +0.1%
Diluted shares 55.41M55.37M55.33M55.36M +0.1%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 8.806.33 -28.1%
Mar 2026 6.308.29 +31.6%
Dec 2025 5.91
Sep 2025 6.406.65 +3.9%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 27.03 3 $26.52B +10.7%
Next year 33.60 4 $29.73B +12.1%

Analyst targets & ownership

Account required
Mean target$610.50
High target$637.00
Low target$570.00
Implied upside21.77%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders68.14%
Held by institutions18.38%
Institutions holding13
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
502.13
-0.16% from price
SMA 20
507.47
-1.13% from price
SMA 50
517.30
-3.01% from price
SMA 100
508.99
-1.50% from price
SMA 200
524.67
-4.37% from price
EMA 12
504.19
-0.56% from price
EMA 26
508.28
-1.36% from price
EMA 50
511.11
-1.91% from price
RSI (14)
46.2
Neutral
MACD (12,26,9)
-4.09
Hist -0.09
ATR (14)
14.57
2.90% of price
Realised vol 30D
29.5%
Annualised
Bollinger upper
524.61
20, 2σ
Bollinger lower
490.33
20, 2σ
50 / 200 cross
Death
517.30 vs 524.67
Trend bias
Below 200
-4.37%

Options chain

Account required
ExpirySpot 501.35
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.31
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
29.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-43.9%
Peak to trough
Max drawdown 5Y
-75.9%
Peak to trough
ATR 14
14.57
2.90% of price
Beta (reported)
0.55
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$0.50 / yr
Forward yield0.10%
5-year avg yield
Payout ratio0.00%
Ex-dividend dateJul 10, 2026
Next pay date
Last split
Split date

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.